Preterm umbilical cord blood derived mesenchymal stem/stromal cells protect preterm white matter brain development against hypoxia-ischemia
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 308, 120-131
Abstract
No abstract availableKeywords
Funding Information
- Victorian Government (APP1081516)
This publication has 67 references indexed in Scilit:
- Stem Cells From Umbilical Cord Wharton’s Jelly From Preterm Birth Have Neuroglial Differentiation PotentialReproductive Sciences, 2013
- Mesenchymal Stem Cells Induce T-Cell Tolerance and Protect the Preterm Brain after Global Hypoxia-IschemiaPLOS ONE, 2013
- Intranasal Mesenchymal Stem Cell Treatment for Neonatal Brain Damage: Long-Term Cognitive and Sensorimotor ImprovementPLOS ONE, 2013
- Macrophage-Associated Mesenchymal Stem Cells Assume an Activated, Migratory, Pro-Inflammatory Phenotype with Increased IL-6 and CXCL10 SecretionPLOS ONE, 2012
- Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemiaStem Cell Research & Therapy, 2011
- The developing oligodendrocyte: key cellular target in brain injury in the premature infantInternational Journal of Developmental Neuroscience, 2011
- Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responsesProceedings of the National Academy of Sciences, 2008
- Neonatal MRI to Predict Neurodevelopmental Outcomes in Preterm InfantsNew England Journal of Medicine, 2006
- Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose TissueStem Cells, 2006
- In vitro mesengenic potential of human umbilical cord blood-derived mesenchymal stem cellsBiochemical and Biophysical Research Communications, 2004